Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Postmenopausal Osteoporoses”

602 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 602 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT06898060
What this trial is testing

To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture

Who this might be right for
Postmenopausal Women With Osteoporosis
Qilu Pharmaceutical Co., Ltd. 282
Testing effectiveness (Phase 2)UnknownNCT03720886
What this trial is testing

G56W1 in Women With Postmenopausal Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Shenzhen Salubris Pharmaceuticals Co., Ltd. 148
Post-approval studies (Phase 4)Study completedNCT00402441
What this trial is testing

Risedronate in the Prevention of Osteoporosis in Postmenopausal Women

Who this might be right for
Osteoporosis, Postmenopausal
Sanofi 260
Post-approval studies (Phase 4)Study completedNCT00460057
What this trial is testing

The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss

Who this might be right for
Osteoporosis
Eulji University Hospital 63
Not applicableStudy completedNCT01401114
What this trial is testing

Wellnara Post-marketing Surveillance in Japan

Who this might be right for
Osteoporosis, Postmenopausal
Bayer 411
Large-scale testing (Phase 3)Study completedNCT00515463
What this trial is testing

A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral Density

Who this might be right for
Low Bone Mineral DensityOsteopeniaOsteoporosis
Amgen 311
Post-approval studies (Phase 4)Study completedNCT06359353
What this trial is testing

Effect of Pitavastatin on Bone

Who this might be right for
Osteoporosis, OsteopeniaHypercholesterolemiaMenopausal Osteoporosis
Seoul National University Bundang Hospital 70
Testing effectiveness (Phase 2)Study completedNCT00306189
What this trial is testing

A Randomized, Double-blind, Placebo-controlled, Dose Response Study of AMG 162 (Denosumab) in Japanese Postmenopausal Osteoporotic Subjects

Who this might be right for
Osteoporosis
Amgen 212
Not applicableUnknownNCT03469518
What this trial is testing

Effect of β-cryptoxanthin (β-Cx), Plant Sterols and Galactooligosaccharides on Systemic and Gastrointestinal Markers

Who this might be right for
HypercholesterolemiaOsteoporosisPostmenopausal Disorder
Puerta de Hierro University Hospital 40
Very early researchUnknownNCT03563235
What this trial is testing

Clinical Study on Treatment of Postmenopausal Osteoporosis (Kidney Deficiency and Blood Stasis Syndrome) With Xulin Jiangu Granules

Who this might be right for
Postmenopausal Osteoporoses
Fujian Academy of Traditional Chinese Medicine 60
Post-approval studies (Phase 4)Active Not RecruitingNCT03623633
What this trial is testing

Comparative Antiresorptive Efficacy Discontinuation of Denosumab

Who this might be right for
Osteoporosis, PostmenopausalOsteoporosis
Massachusetts General Hospital 51
Large-scale testing (Phase 3)Study completedNCT01343004
What this trial is testing

Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women

Who this might be right for
OsteoporosisPostmenopausal Osteoporosis
Radius Health, Inc. 2,463
Post-approval studies (Phase 4)Study completedNCT02598934
What this trial is testing

Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis

Who this might be right for
Post Menopausal Osteoporosis
Hoffmann-La Roche 308
Not applicableLooking for participantsNCT06947213
What this trial is testing

Orthorexia Nervosa in Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis
Beylikduzu State Hospital 128
Testing effectiveness (Phase 2)UnknownNCT02630797
What this trial is testing

Effect of Blueberries on Bone Turnover

Who this might be right for
Osteoporosis, PostmenopausalBone Loss, Age-related
Purdue University 20
Not applicableUnknownNCT00079248
What this trial is testing

Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer

Who this might be right for
Breast CancerHot FlashesMenopausal Symptoms+1 more
Institute of Cancer Research, United Kingdom
Post-approval studies (Phase 4)Study completedNCT00405392
What this trial is testing

Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis, Postmenopausal
GlaxoSmithKline 365
Early research (Phase 1)Study completedNCT00499928
What this trial is testing

Investigate The Metabolism And Excretion Of 14C SB-751689 Given To Healthy Males And Postmenopausal Women

Who this might be right for
Osteoporosis
GlaxoSmithKline 6
Not applicableStudy completedNCT00984893
What this trial is testing

Intra-venous Zoledronic Acid Once Yearly

Who this might be right for
Post-Menopausal Osteoporosis
Novartis Pharmaceuticals 1,551
Not applicableStudy completedNCT00591747
What this trial is testing

Strength Training for Older Breast Cancer Survivors

Who this might be right for
Breast NeoplasmOsteoporosis, Postmenopausal
OHSU Knight Cancer Institute 106
Load More Results